Alvotech (ALVO) Operating Expenses (2021 - 2026)
Alvotech's (ALVO) quarterly Operating Expenses came in at -$50.2 million in Q1 2026, up 11.61% YoY from -$45.0 million in Q1 2025, and down 110.22% on a QoQ basis from $490.9 million in Q4 2025.
Alvotech (ALVO) Operating Expenses (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Operating Expenses data on file, last reported at -$50.2 million in Q1 2026.
- Quarterly Operating Expenses rose 11.61% year-over-year to -$50.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $281.7 million (up 159.79% YoY) and the FY2025 annual result came in at $275.1 million, up 16.08% from the prior year.
- Operating Expenses eased to -$50.2 million in Q1 2026, from $490.9 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $490.9 million in Q4 2025 to a low of -$367.4 million in Q4 2022.
- A 5-year average of -$92.9 million and a median of -$81.5 million in 2025 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 307.12% in 2025, down 86773.43% in 2025.
- Tracing ALVO's Operating Expenses over 5 years: stood at -$367.4 million in 2022, then rose by 21.77% to -$287.4 million in 2023, then grew by 17.52% to -$237.0 million in 2024, then surged by 307.12% to $490.9 million in 2025, then plunged by 110.22% to -$50.2 million in 2026.
- The last three Operating Expenses figures came in at -$50.2 million (Q1 2026), $490.9 million (Q4 2025), and -$77.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alvotech | 1.17 Bn | 1.17 Bn | 5.09 Mn | -50.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.18 Mn |
| Dec 31, 2025 | 490.92 Mn |
| Sep 30, 2025 | -77.54 Mn |
| Jun 30, 2025 | -81.46 Mn |
| Mar 31, 2025 | -56.78 Mn |
| Dec 31, 2024 | -237.03 Mn |
| Sep 30, 2024 | -50.45 Mn |
| Jun 30, 2024 | -126.97 Mn |
| Mar 31, 2024 | -65,356.00 |
| Dec 31, 2023 | -287.39 Mn |
| Aug 31, 2023 | -141.49 Mn |
| Jun 30, 2023 | -141.42 Mn |
| Mar 31, 2023 | -73,062.00 |
| Dec 31, 2022 | -367.36 Mn |
| Aug 31, 2022 | -226.03 Mn |
| Jun 30, 2022 | -154.72 Mn |
| Mar 31, 2022 | -71.31 Mn |
| Dec 31, 2021 | 528.05 Mn |
| Sep 30, 2021 | -76.15 Mn |